Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell Malignancies

Clinical trial NCT05127135 · UNKNOWN

Trial details

NCT number: NCT05127135
Sponsor: Fundamenta Therapeutics, Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T-Acute Lymphoblastic Leukemia T-cell Non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Lymphoma

Start date: 2020-01-22
Primary completion: 2023-01-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.